Heart Focused Breathing for Alzheimer's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Arizona State University, Phoenix, AZ
Alzheimer's Disease+1 More
Heart Focused Breathing - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

In a remotely delivered nationwide pilot study, we will be examining a novel 8-week heart rate variability biofeedback (HRVB) intervention vs music listening control (MLC) for 30 family caregivers 18 years and older (FCGs) of Alzheimer's disease (AD) (and related dementias: ADRD) patients to examine feasibility (acceptability/adherence, satisfaction) and direction of change in caregiver burden, stress, resilience, anxiety, self-compassion, and relationship quality.

Eligible Conditions

  • Alzheimer's Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: 13 weeks

13 weeks
Brief Resilience Scale
Perceived Stress Scale-10
Zarit Burden Interview

Trial Safety

Trial Design

2 Treatment Groups

Music Listening Control(MLC)
1 of 2
Heart Focused Breathing
1 of 2
Active Control
Experimental Treatment

30 Total Participants · 2 Treatment Groups

Primary Treatment: Heart Focused Breathing · No Placebo Group · N/A

Heart Focused Breathing
Behavioral
Experimental Group · 1 Intervention: Heart Focused Breathing · Intervention Types: Behavioral
Music Listening Control(MLC)
Behavioral
ActiveComparator Group · 1 Intervention: Music Listening Control (MLC) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 13 weeks
Closest Location: Arizona State University · Phoenix, AZ
Photo of Phoenix 1Photo of Phoenix 2Photo of Phoenix 3
2006First Recorded Clinical Trial
0 TrialsResearching Alzheimer's Disease
63 CompletedClinical Trials

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
234 Previous Clinical Trials
88,408 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a minimum age of 18 years.
You are a primary caregiver for an ADRD patient for 6 months or more.
You own and operate a smartphone with a data plan.
You are greater than 4 on the caregiver burden scale.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.